chartexchange

TCRT
Alaunos Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseNov 2, 2026 3:59:50 PM EST
1.75USD-10.000%(-0.20)159,332
Pre-marketNov 2, 2026 9:28:30 AM EST
1.93USD-1.026%(-0.02)
After-hoursNov 2, 2026 4:32:30 PM EST
1.7513USD-0.211%(-0.0037)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Houston, TX, USA
Previous Close
$1.95
Beta
1.35
52-Week High
$4.50 2025-12-12
52-Week Low
$0.72 2026-10-06
SMA 50
$1.64
SMA 200
$2.33
Avg. Vol 10D
5.36M
Avg. Vol 30D
14.46M
Avg. Vol 90D
5.36M
Relative Vol
0.01
2.33M
338.2500%
523,112
Nov 13, 2026 (10d)
Jul 18, 2024 · 1-for-10 (reverse)
TCRT Profile

ziopharm oncology, inc., is a biopharmaceutical company focused on the discovery and development of new cancer therapies. we are applying the latest technologies in cancer research to develop safer, more precise therapeutics to improve care and quality of life for patients.

TCRT Performance
PeriodPriceDateChangeBeta
1W2.132026-10-26-17.61%-1.348
1M0.822026-10-02+114.02%3.577
3M1.912026-08-03-7.87%2.669
6M2.612026-05-01-32.76%1.890
1Y2.712025-11-03-35.24%1.353
2Y2.042024-11-01-13.97%—
5Y135.002022-01-28-98.70%1.116
TCRT Stock Summary

Alaunos Therapeutics, Inc. Common Stock (NASDAQ:TCRT) stock price today is $1.76, and today's volume is 147,589. TCRT is down 10.000% today. The 30 day average volume is 14.46M. TCRT market cap is $4.46M with 2.54M shares outstanding.